Screening of depression in cardiology: A study on 617 cardiovascular patients

Tesio, Valentina; Marra, Sebastiano; Molinaro, Stefano; Torta, Riccardo; Gaïta, Fiorenzo; Castelli, Lorys

doi:10.1016/j.ijcard.2017.07.065

Cited by 14 publications

(11 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These psychiatric disorders are present in large portion of the population after the occurrence of acute coronary syndrome (ACS), which covers the acute myocardial infarction with STsegment elevation (STEMI), non-ST segment elevation (NSTE), and unstable angina (UA). Anxiety affects between 20 and 50% of this population, while depressive symptoms are present between 15 and 45% of the population (3)(4) .…”

Section: Introductionmentioning

confidence: 99%

Impact of anxiety and depression on morbidity and mortality of patients with coronary syndrome

et al. 2018

View full text Add to dashboard Cite

Objective: Evaluate the impact of anxiety and depression on morbidity and mortality of patients with acute coronary syndrome. Method: Retrospective cohort study, with follow-up of two years, conducted with 94 patients. The morbidity and mortality (readmission, myocardial revascularization, and death) was evaluated immediately after discharge and after one and two years. Anxiety and depression were evaluated by the State-Trait Anxiety Inventory and by Beck’s Depression Inventory. The Kaplan-Meier estimator and the Logrank test were used. The significance level adopted was 0.05. Results: We observed that 76.6% of the patients did not present symptoms of depression or had mild signs, while 78.8% had low to moderate anxiety. The symptoms of depression and anxiety were not related to morbidity (need for MR p=0.098 and 0.56, respectively; readmission p=0.962 and 0.369, respectively) and mortality (p=0.434 and 0.077, respectively). Conclusion: No relationship was found between levels of anxiety and depression with the morbidity and mortality of patients.

show abstract

Section: Introductionmentioning

confidence: 99%

Impact of anxiety and depression on morbidity and mortality of patients with coronary syndrome

et al. 2018

View full text Add to dashboard Cite

show abstract

“…In this analysis, non‐substance abuse mental illness in aggregate was demonstrated to be associated with worse outcomes for patients with stable angina. As screening for depression remains underutilized, there is likely even less implementation of screening for other mental health conditions in these vulnerable patients. Furthermore, to our knowledge, there have been no randomized trials of interventions in PCI patients with non‐depression psychiatric conditions.…”

Section: Discussionmentioning

confidence: 99%

Mental illness and obesity among Veterans undergoing percutaneous coronary intervention: Insights from the VA CART program

et al. 2019

View full text Add to dashboard Cite

Mental illness and obesity are highly prevalent in patients with coronary disease and are frequently comorbid. While mental illness is an established risk factor for major adverse cardiac and cerebrovascular events (MACCEs), prior studies suggest improved outcomes in people with obesity. It is unknown if obesity and mental illness interact to affect cardiac outcomes or if they independently influence MACCE. We identified 55 091 patients undergoing percutaneous coronary intervention (PCI) between 2009 and 2014, using the Veterans Affairs (VA) Clinical Assessment Reporting and Tracking (CART) program. Cox methods were used to assess the risk of MACCE by weight status and psychiatric diagnosis, and assessed for interaction. Compared to normal weight status, higher weight was associated with reduced MACCE events after PCI (mean follow‐up of 2 years) for both stable angina and acute coronary syndromes (ACSs; reduction of >13% in stable angina, >17% in ACS; P < 0.01 for both after adjustment). Having a non‐substance abuse mental illness diagnosis increased risk of MACCE compared to patients without mental illness in stable angina over 17%; P < 0.05, but not in ACS. When analysed for interaction, obesity and mental illness did not significantly impact MACCE over their independent influences. These results suggest that mental illness along with weight status have significant impact on MACCE, post‐PCI. Clinicians should be aware of patients' mental health status as a significant cardiovascular risk factor after PCI, independent of weight status.

show abstract

“…Major depressive disease (MDD) is a frequently recurring or chronic psychiatric disease with high prevalence 1,2 and is characterized by alterations in affect and mood. Of utmost importance is the association of MDD with high rates of suicidality and mortality 3,4,5,6 . Pharmacological treatment strategies include monoamine neurotransmitter reuptake inhibition [e.g., treatment with selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs)], lithium augmentation, or atypical antipsychotic augmentation strategies 7,8 .…”

Section: Introductionmentioning

confidence: 99%

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Moeller

Lücke

Heinen

et al. 2019

JoVE

View full text Add to dashboard Cite

Vagus nerve stimulation (VNS) is an approved neurostimulation therapy. The purpose of the method is to treat patients with therapy-resistant depression (TRD). VNS exhibits antidepressive and stabilizing effects. This method is particularly useful as a long-term treatment, in which up to two-thirds of patients respond. The vagus nerve stimulator is positioned on the left vagus nerve during a surgical procedure and is activated telemetrically by a wand connected to a handheld computerized device. The treating physician can perform various adjustments of the vagus nerve stimulator during in-office visits (e.g., by modifying stimulation intensity or stimulation frequency) to achieve maximum therapeutic effects with low side effects. Setup of the device usually takes several months. Typical side effects include wound infection, temporary salivation, coughing, paralysis of the vocal cords, bradycardia, or even asystole. The patient can stop the VNS by placing a magnet over the generator. The current protocol describes delivery of the specific stimulation tool and methods for adjusting the tuning parameters to achieve the best remission rates in patients with TRD.

show abstract

Screening of depression in cardiology: A study on 617 cardiovascular patients

Cited by 14 publications

References 23 publications

Impact of anxiety and depression on morbidity and mortality of patients with coronary syndrome

Impact of anxiety and depression on morbidity and mortality of patients with coronary syndrome

Mental illness and obesity among Veterans undergoing percutaneous coronary intervention: Insights from the VA CART program

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Contact Info

Product

Resources

About